Price T Rowe Associates Inc ARRIVENT BIOPHARMA INC Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025
Number of Shares
11,453
Previous 12,471 8.16%
Holding current value
$250,000
Previous $231,000 8.23%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-1,018 Reduced 8.16%
11,453 $250,000
Q1 2025

May 14, 2025
BUY
N/A
1,506 Added 13.73%
12,471 $231,000
Q4 2024

Feb 14, 2025
BUY
N/A
1,620 Added 17.34%
10,965 $293,000
Q3 2024

Nov 14, 2024
BUY
N/A
9,345 New
9,345 $220,000
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email